pimobendan has been researched along with natriuretic peptide, brain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komamura, K; Kubo, T; Nishikimi, T; Sasaki, T | 1 |
| Kasanuki, H; Matsuda, N; Naganuma, M; Shiga, T; Tatami, S; Wakaumi, M | 1 |
| Arakawa, S; Hayano, M; Kawano, H; Maemura, K; Matsumoto, Y; Nakatomi, D; Satoh, O; Yamasa, T | 1 |
| Block, CL; Hezzell, MJ; Laughlin, DS; Oyama, MA | 1 |
| Bach, JP; Iwanuk, N; Nolte, I; Pilgram, A; Raue, J; Rumstedt, K; Sehn, M; Wall, L | 1 |
4 trial(s) available for pimobendan and natriuretic peptide, brain
| Article | Year |
|---|---|
Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Phosphodiesterase Inhibitors; Prospective Studies; Pyridazines; Stroke Volume; Vasodilator Agents | 1999 |
Plasma concentration profile of orally administered pimobendan and plasma brain natriuretic peptide level in patients with severe heart failure.
Topics: Administration, Oral; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Failure; Humans; Natriuretic Peptide, Brain; Pyridazines | 2003 |
Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotonic Agents; Diuretics; Dog Diseases; Dogs; Female; Heart Failure; Male; Mitral Valve Insufficiency; Natriuretic Peptide, Brain; Peptide Fragments; Pyridazines | 2018 |
Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
Topics: Animals; Biomarkers; Dog Diseases; Dogs; Exercise Test; Female; Heart Valve Diseases; Male; Natriuretic Peptide, Brain; Peptide Fragments; Physical Conditioning, Animal; Pyridazines; Random Allocation; Stress, Physiological; Treatment Outcome; Troponin I | 2019 |
1 other study(ies) available for pimobendan and natriuretic peptide, brain
| Article | Year |
|---|---|
Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiotonic Agents; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Patient Readmission; Pyridazines; Time Factors; Treatment Outcome; Ventricular Function, Left | 2014 |